Atlas Trials

Apatinib Plus Concurrent Neoadjuvant Chemoradiotherapy for Gastroesophageal Junction

Clinical trial NCT03986385 · UNKNOWN

Trial details

NCT number
NCT03986385
Sponsor
Hebei Medical University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Gastroesophageal Junction Adenocarcinoma
Start date
2019-06-01
Primary completion
2020-06-30
Enrollment
180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.